After drugmaker Pfizer Inc. moved to quash the depositions of two high-ranking executives in litigation over antidepressant Zoloft, the plaintiffs said that it is unlikely that those executives wouldn’t have relevant knowledge about the large mass tort litigation.
Pfizer is seeking to quash the depositions of Dr. Joseph Feczko, who was Pfizer’s chief medical officer until his retirement five years ago, and Dr. Patrizia Cavazzoni, Pfizer’s senior vice president of safety, established pharma & generic regulatory.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
